TrianglePUBLICATIONS · 1824249
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 1991 Nov 15
- First author
- Dillman RO
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Dillman RO
- type
- Author
- name
- Davis RB
- type
- Author
- name
- Green MR
- type
- Author
- name
- Weiss RB
- type
- Author
- name
- Gottlieb AJ
- type
- Author
- name
- Caplan S
- type
- Author
- name
- Kopel S
- type
- Author
- name
- Preisler H
- type
- Author
- name
- McIntyre OR
- type
- Author
- name
- Schiffer C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Dillman RO
- type
- Author
- name
- Davis RB
- type
- Author
- name
- Green MR
- type
- Author
- name
- Weiss RB
- type
- Author
- name
- Gottlieb AJ
- type
- Author
- name
- Caplan S
- type
- Author
- name
- Kopel S
- type
- Author
- name
- Preisler H
- type
- Author
- name
- McIntyre OR
- type
- Author
- name
- Schiffer C
- type
- Author
- bibliography ids
- nci-bib-b1933f94b0daaed0b2202e06
- book metadata
- content sha256
- 2e5cb27cdf82a0991743c47ff6834a7c1c648134a8cad4c8874e7bf901a43cee
- document type
- citation
- dois
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:1824249
- immutable id
- pubmed:1824249@2e5cb27cdf82a0991743c47ff6834a7c1c648134a8cad4c8874e7bf901a43cee
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 10
- name
- Blood
- nlm unique id
- 7603509
- pages
- 2520-6
- volume
- 78
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 1824249
- provenance
- batch id
- 4dd31a34efbe4b9fe1c1
- provider
- NCBI PubMed ESummary
- record sha256
- bc41de8bdf79b4beead0a75495ebe5f085de7cb75be7d7e259fcce07716850c2
- response sha256
- 6a38fb0063e4902598a1efcc0d1821501cf82821747967b29fe13940a1d400ba
- retrieved at
- 2026-09-09T23:45:07.034965+00:00
- publication date
- display
- 1991 Nov 15
- precision
- day
- year
- 1991
- publication types
- Clinical Trial
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/1824249/
- title
- A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B.
Preserved source evidence · Not medical advice